Cite

    Marasca, C. et al. (2019). Long‐term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side‐effects, improving patients' compliance. British journal of dermatology. p. 949. [Online].